Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate-Reference-Cited by-同舟云学术

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

Published:1993-01 Issue:9 Volume:29 Page:1280-1284
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Levi Francis,Perpoint Bruno,Garufi Carlo,Focan Christian,Chollet Philippe,Depres-Brummer Petra,Zidani Rachid,Brienza Silvano,Itzhaki Moshe,Iacobelli Stefano,Kunstlinger Francis,Gastiaburu Julio,Misset Jean-Louis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Antitumour activity of platinum II complexes of 1,2-diammino-cyclohexane isomers;Kidani;Jpn J Cancer Res,1980

2. Antitumor activity of L-OHP in mice;Mathé;Cancer Lett,1985

3. Oxalato-platinum or L-OHP, a third generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum;Mathé;Biomed Pharmacother,1989

4. Phase I study of oxaliplatin in patients with advanced cancer;Extra;Cancer Chemother Pharmacol,1990

5. Early phase II trial of trans-1-diammino cyclohexane oxalatoplatine (L-OHP) in malignant melanoma, ovarian carcinoma and non-Hodgkin's lymphoma (NHL).;Misset,1991

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronotoxici‐Plate Containing Droplet‐Engineered Rhythmic Liver Organoids for Drug Toxicity Evaluation;Advanced Science;2024-05-08

2. Identification of potential circadian genes and associated pathways in colorectal cancer progression and prognosis using microarray gene expression analysis;Circadian System;2023

3. Circadian clock as a possible control point in colorectal cancer progression (Review);International Journal of Oncology;2022-10-17

4. Prognostic significance of intrahepatic lymphatic invasion in colorectal liver metastases;Annals of Diagnostic Pathology;2022-10

5. Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity;Methods in Molecular Biology;2022